rs201117318

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_001039141.3(TRIOBP):​c.4783C>T​(p.Arg1595Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000082 in 1,609,002 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000057 ( 1 hom. )

Consequence

TRIOBP
NM_001039141.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: -1.81
Variant links:
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.004541278).
BP6
Variant 22-37735119-C-T is Benign according to our data. Variant chr22-37735119-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 228034.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=3}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000322 (49/152252) while in subpopulation AFR AF= 0.00113 (47/41548). AF 95% confidence interval is 0.000874. There are 0 homozygotes in gnomad4. There are 22 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIOBPNM_001039141.3 linkc.4783C>T p.Arg1595Cys missense_variant Exon 9 of 24 ENST00000644935.1 NP_001034230.1 Q9H2D6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIOBPENST00000644935.1 linkc.4783C>T p.Arg1595Cys missense_variant Exon 9 of 24 NM_001039141.3 ENSP00000496394.1 Q9H2D6-1
TRIOBPENST00000344404.10 linkn.*4266C>T non_coding_transcript_exon_variant Exon 7 of 22 2 ENSP00000340312.6 H7BXW4
TRIOBPENST00000344404.10 linkn.*4266C>T 3_prime_UTR_variant Exon 7 of 22 2 ENSP00000340312.6 H7BXW4

Frequencies

GnomAD3 genomes
AF:
0.000322
AC:
49
AN:
152134
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000134
AC:
33
AN:
245650
Hom.:
1
AF XY:
0.0000969
AC XY:
13
AN XY:
134126
show subpopulations
Gnomad AFR exome
AF:
0.00172
Gnomad AMR exome
AF:
0.0000872
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000272
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000570
AC:
83
AN:
1456750
Hom.:
1
Cov.:
36
AF XY:
0.0000497
AC XY:
36
AN XY:
723748
show subpopulations
Gnomad4 AFR exome
AF:
0.00174
Gnomad4 AMR exome
AF:
0.0000672
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000812
Gnomad4 OTH exome
AF:
0.000133
GnomAD4 genome
AF:
0.000322
AC:
49
AN:
152252
Hom.:
0
Cov.:
32
AF XY:
0.000296
AC XY:
22
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.00113
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000262
Hom.:
0
Bravo
AF:
0.000438
ESP6500AA
AF:
0.00129
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000157
AC:
19

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Mar 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 17, 2023
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 32579932) -

Inborn genetic diseases Uncertain:1
Sep 15, 2021
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.4783C>T (p.R1595C) alteration is located in exon 9 (coding exon 7) of the TRIOBP gene. This alteration results from a C to T substitution at nucleotide position 4783, causing the arginine (R) at amino acid position 1595 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not specified Benign:1
May 17, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Arg1595Cys in exon 9 of TRIOBP: This variant is not expected to have clinical si gnificance because the arginine (Arg) residue at position 1595 is not conserved through species, with 8 mammals having a cystine (Cys) at this position. It has been identified in 0.15% (14/9258) of African chromosomes by the Exome Aggregati on Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs201117318). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
8.2
DANN
Uncertain
1.0
DEOGEN2
Benign
0.040
T;T
Eigen
Benign
-0.91
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.043
N
LIST_S2
Benign
0.47
.;T
M_CAP
Benign
0.0071
T
MetaRNN
Benign
0.0045
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.81
L;L
PrimateAI
Benign
0.25
T
PROVEAN
Uncertain
-2.5
D;.
REVEL
Benign
0.036
Sift
Benign
0.17
T;.
Sift4G
Benign
0.069
T;.
Polyphen
0.018
B;B
Vest4
0.048
MVP
0.24
MPC
0.16
ClinPred
0.033
T
GERP RS
-2.0
Varity_R
0.075
gMVP
0.036

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201117318; hg19: chr22-38131126; API